Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia.

Avivit Cahn, Hagit Shoyhet-Smoilovsky, Matan Fischer, Aviad Zick, Yael Riahi, Shulamit Levenberg, Gil Leibowitz

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia This letter describes the use of alpelisib, a PI3 kinase inhibitor, to successfully treat severe hypoglycemia in a patient with intractable non-islet-cell tumor hypoglycemia.

Original languageEnglish
Pages (from-to)1911-1913
Number of pages3
JournalNew England Journal of Medicine
Issue number20
StatePublished - 2023


  • Clinical Medicine
  • Clinical Medicine General
  • Endocrinology
  • Endocrinology General
  • Hematology/Oncology
  • Treatments in Oncology

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Alpelisib in Intractable Non-Islet-Cell Tumor Hypoglycemia.'. Together they form a unique fingerprint.

Cite this